Received Jun 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | 1 | 3055152 | IM / RA |
| RSV | RSV (MRESVIA) | MODERNA | 1 | 3051132 | IM / LA |
Normal BM at 1000, vaccine administer at 1030 (mNEXSPIKE and mRESVIA), dizzy/lightheaded at approximately 1230, significant blood loss/clots with BM at 1230, transferred to hospital (name and location withheld), received transfusion, ICD-10-CM: K62.5 BRBPR(bright red blood per rectum)
no acute illness - vital stable at time of vaccine
non-ischemic myocardial injury(non-traumatic), emphysema, other forms of dyspnea, chronic diastolic(congestive) heart failure, paroxysmal atrial fibrillation, asthma, type 2 DM w/o complications, obesity class 3, OSA, chronic pain, low back pain, amnesia, major depressive disorder, recurrent, essential hypertension, hyperlipidemia, deficiency of other specified B group vitamins, BPH with lower urinary tract symptoms, frequency of micturition, personal history of nicotine dependence
albuterol, aspirin, B12 oral, calcium+D, carvedilol, empagliflozin, finasteride, fluticasone, furosemide, ipratropium-albuterol, losartan potassium, metformin, nystatin, rosuvastatin calcium, trazadone,
environmental - severity unknown
Hgb - 7.4